<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>mda_056 â€“ MD&amp;A Earlier</title>
    <style>
        body {
            font-family: Arial, Helvetica, sans-serif;
            line-height: 1.6;
            margin: 40px;
        }
        p {
            margin-bottom: 1em;
        }
    </style>
</head>
<body>
<p>Warrants Outstanding<br>
 <br>
As a result of our borrowings described above there were warrants outstanding to purchase shares of our common stock as shown in the table below:</p>

<p>[DATA_TABLE_REMOVED]</p>

<p>(1)<br>
Warrants issued in connection with the Contingent Equity Agreement have a five-year exercise period from issuance. These warrants were originally issued between June 2009 and June 2012 and the exercise periods related to the remaining unexercised warrants will expire from June 2015 to June 2017.<br>
(2)<br>
The exercise period of the warrants issued in connection with the Thermo Loan Agreement was five years from issuance, which ended June 2014. Thermo exercised all of these warrants in the second quarter of 2014.<br>
(3)<br>
The 5.0% Warrants are exercisable until five years after their issuance, which is June 2016.<br>
(4)<br>
The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 14, 2014. All 8.00% Warrants were exercised in the second quarter of 2014.</p>
</body>
</html>
